Gov't creates office for medical products regulation planning

The body will review existing laws for possible amendments. 

The Department of Health established a preparatory office for the Hong Kong Centre for Medical Products Regulation (CMPR) to initiate its formal formation.

The preparatory office will study and plan a regulatory and approval regime for drugs and medical devices. It will also review existing policies and possibly recommend amendments to the Steering Committee on Health and Medical Innovation Development.

According to authorities, “Hong Kong would become an internationally renowned regulatory authority and implement the ‘primary evaluation’ approach for medical products in six major steps.”

Hong Kong has completed the first three steps, including the preparatory office establishment.

The government announced plans to attract more pharmaceutical and medical device firms to undertake research, development, and clinical trials in Hong Kong.

They will also be encouraged to contribute to building capacity, recognition, and status to ensure that the approval mechanism of medical products in Hong Kong is widely recognised, making the city an international health and medical innovation hub.